We report here a series of new inhibitors of the X-linked inhibitor of apoptosis protein (XIAP protein) based on the SMAC-tetrapeptide AVPI. The structural novelty of these molecules is the presence of the proline mimetic exo-2-azabicyclo[2.2.1]heptane-3-carboxylic acid, leading to analogs with similar activity to the natural ligand peptide. The structure–activity relationship and computational docking studies support the convenience of this unnatural amino acid as a building block to develop new peptides or small molecules targeting the XIAP-BIR3 domain.
LaCasseEC, BairdS, KornelukRG, MacKenzieAE. The inhibitors of apoptosis (IAPs) and their emerging role in cancer. Oncogene1998;17:3247–59
2.
ListonP, RoyN, TamaiK, LefebvreC, BairdS, Cherton-HorvatG, FarahaniR, McLeanM, IkedaJ, MacKenzieA, KornelukRG. Suppression of apoptosis in mammalian cells by NAIP and a related family of IAP genes. Nature1996;379:349–52
3.
DeverauxQL, LeoE, StennickeHR, WelshK, SalvesenGS, ReedJC. Cleavage of human inhibitor of apoptosis protein XIAP results in fragments with distinct specificities for caspases. EMBO J1999;18:5242–51
4.
DuC, FangM, LiY, LiL, WangX. Smac, a mitochondrial protein that promotes cytochrome c–dependent caspase activation by eliminating IAP inhibition. Cell2000;102:33–42
5.
VerhagenAM, EkertPG, PakuschM, SilkeJ, ConnollyLM, ReidGE, MoritzRL, SimpsonRJ, VauxDL. Identification of DIABLO, a mammalian protein that promotes apoptosis by binding to and antagonizing IAP proteins. Cell2000;102:43–53
6.
WuG, ChaiJ, SuberTL, WuJ, DuC, WangX, ShiY. Structural basis of IAP recognition by Smac/DIABLO. Nature2000;408:1008–12
7.
SrinivasulaSM, HegdeR, SalehA, DattaP, ShiozakiE, ChaiJ, LeeR, RobbinsPD, Femandes-AlnemriT, ShiY, AlnemriES. A conserved XIAP-interaction motif in caspase-9 and Smac/DIABLO regulates caspase activity and apoptosis. Nature2001;410:112–6
8.
OostTK, SunC, ArmstrongRC, Al-AssaadAS, BetzSF, DeckwerthTL, DingH, ElmoreSW, MeadowsRP, OlejniczakET, OleksijewA, OltersdorfT, RosenbergSH, ShoemakerAR, TomaselliKJ, ZouH, FesikSW. Discovery of potent antagonists of the antiapoptotic protein XIAP for the treatment of cancer. J Med Chem2004;47:4417–26
9.
GuoF, NimmanapalliR, ParanawithanaS, WittmanS, GriffinD, BaliP, O'BryanE, FumeroC, WangHG, BhallaK. Ectopic overexpression of second mitochondria-derived activator of caspases (Smac/DIABLO) or cotreatment with N-terminus of Smac/DIABLO peptide potentiates epothilone B derivative-(BMS 247550) and Apo-2L/TRAIL-induced apoptosis. Blood2002;99:3419–26
10.
YangL, MashimaT, SatoS, MochizukiM, SakamotoH, YamoriT, Oh-HaraT, TsuruoT. Predominant suppression of apoptosome by inhibitor of apoptosis protein in non-small cell lung cancer H460 cells: therapeutic effect of a novel polyarginine-conjugated Smac peptide. Cancer Res2003;63:831–7
11.
SchimmerAD, DaliliS, BateyRA, RiedlS. Targeting XIAP for the treatment of malignancy. Cell Death Differ2006;13:179–88
12.
StellaL, AbrahamH, Feneau-DupontJ, TinantB, DeclerqJP. Asymmetric aza-diels-alder reaction using the chiral 1-phenyl ethyl imine of methyl glyoxylate. Tetrahedron Lett1990;31:2603–6
13.
GoodsellDS, OlsonAJ. Automated docking of substrates to proteins by simulated annealing. Prot Struct Func Genet1990;8:195–202
14.
MorrisGM, GoodsellDS, HueyR, OlsonAJ. Distributed automated docking of flexible ligands to proteins: parallel applications of AutoDock 2.4. J Comput Aided Mol Des1996;10:293–304
15.
MorrisGM, GoodsellDS, HallidayRS, HueyR, HartWE, BelewRK, OlsonAJ. Automated docking using a lamarckian genetic algorithm and an empirical binding free energy function. J Comput Chem1998;19:1639–62
16.
DeLanoW. The PyMol Molecular Graphics System. San Carlos, CA, USA: DeLano Scientific LLC. See http://www.pymol.org (last checked 11 January 2011)
17.
LuKP, FinnG, LeeTH, NicholsonLK. Prolyl cis-trans isomerization as a molecular timer. Nat Chem Biol2007;3:619–29
18.
SinghN, MaZ, GemmillT, WuX, DefiglioH, RossettiniA, RabelerC, BeaneO, MorseRH, PalumboMJ, HanesSD. The Ess1 prolyl isomerase is required for transcription termination of small noncoding RNAs via the Nrd1 pathway. Mol Cell2009;36:255–66
19.
WangZ, SongJ, MilneTA, WangGG, LiH, AllisCD, PatelDJ. Pro isomerization in MLL1 PHD3-bromo cassette connects H3K4me readout to CyP33 and HDAC-mediated repression. Cell2010;141:1183–94
20.
RudrabhatlaP, PantHC. Phosphorylation-specific peptidyl-prolyl isomerization of neuronal cytoskeletal proteins by Pin1: implications for therapeutics in neurodegeneration. J Alzheimers Dis2010;19:389–403
21.
BeausoleilE, LubellWD. Steric effects on the amide isomer equilibrium of prolyl peptides. Synthesis and conformational analysis of N-Acetyl-5-tert-butylproline N'-Methylamides. J Am Chem Soc1996;118:12902–8
22.
BeausoleilE, SharmaR, MichnickSW, LubellWD. Alkyl 3-position substituents retard the isomerization of prolyl and hydroxyprolyl amides in water. J Org Chem1998;63:6572–8
23.
Lopez-VeraE, WalewskaA, SkalickyJJ, OliveraBM, BulajG. Role of hydroxyprolines in the in vitro oxidative folding and biological activity of conotoxins. Biochemistry2008;47:1741–51
24.
AnSS, LesterCC, PengJ, LiY, RothwarfDM, WelkerE, ThannhauserTW, ZhangLS, TamJP, ScheragaHA. Retention of the cis proline conformation in tripeptide fragments of bovine pancreatic ribonuclease a containing a non-natural proline analogue, 5,5-dimethylproline. J Am Chem Soc1999;121:11558–66
